Cytosorbents
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.About CTSO
CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb.
CTSO Key Statistics
Stock Snapshot
As of today, Cytosorbents(CTSO) shares are valued at $0.35. The company's market cap stands at 22.14M, with a P/E ratio of -1.21.
On 2026-09-04, Cytosorbents(CTSO) stock moved within a range of $0.32 to $0.40. With shares now at $0.35, the stock is trading +7.9% above its intraday low and -13.7% below the session's peak.
Trading volume for Cytosorbents(CTSO) stock has reached 768.21K, versus its average volume of 759.83K.
The stock's 52-week range extends from a low of $0.30 to a high of $1.04.
The stock's 52-week range extends from a low of $0.30 to a high of $1.04.
CTSO News
(RTTNews) - Thursday, Cytosorbents Corporation (CTSO) announced its plan to implement a one-for-twenty reverse stock split of its common stock, par value $0.001...
CytoSorbents (CTSO) Corporation announced that it will effect a one-for-twenty reverse stock split of its common stock, par value $0.001 per share. The Reverse...
CytoSorbents (CTSO) announced an independent new patient-level matched analysis of real-world data demonstrating that intraoperative use of CytoSorb was associa...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.